Your browser doesn't support javascript.
SARS-CoV-2 vaccine uptake, perspectives, and adverse reactions following vaccination in patients with cancer undergoing treatment.
Figueiredo, J C; Ihenacho, U; Merin, N M; Hamid, O; Darrah, J; Gong, J; Paquette, R; Mita, A C; Vescio, R; Mehmi, I; Basho, R; Salvy, S J; Shirazipour, C H; Caceres, N; Finster, L J; Coleman, B; Arnow, H U; Florindez, L; Sobhani, K; Prostko, J C; Frias, E C; Stewart, J L; Merchant, A; Reckamp, K L.
  • Figueiredo JC; Division of Medical Oncology, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, USA. Electronic address: Jane.Figueiredo@cshs.org.
  • Ihenacho U; Division of Medical Oncology, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, USA; Keck School of Medicine, University of Southern California, Los Angeles, USA.
  • Merin NM; Division of Medical Oncology, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, USA.
  • Hamid O; The Angeles Clinic and Research Institute, Cedars-Sinai Medical Center, Los Angeles, USA.
  • Darrah J; Division of Medical Oncology, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, USA.
  • Gong J; Division of Medical Oncology, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, USA.
  • Paquette R; Division of Medical Oncology, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, USA.
  • Mita AC; Division of Medical Oncology, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, USA.
  • Vescio R; Division of Medical Oncology, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, USA.
  • Mehmi I; Division of Medical Oncology, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, USA.
  • Basho R; Division of Medical Oncology, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, USA.
  • Salvy SJ; Division of Medical Oncology, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, USA.
  • Shirazipour CH; Division of Medical Oncology, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, USA; Department of Medicine, University of California Los Angeles, Los Angeles, USA.
  • Caceres N; Division of Medical Oncology, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, USA.
  • Finster LJ; Division of Medical Oncology, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, USA.
  • Coleman B; Department of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, USA.
  • Arnow HU; Department of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, USA.
  • Florindez L; Department of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, USA.
  • Sobhani K; Division of Medical Oncology, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, USA.
  • Prostko JC; Abbott Diagnostics, Abbott Park, USA.
  • Frias EC; Abbott Diagnostics, Abbott Park, USA.
  • Stewart JL; Abbott Diagnostics, Abbott Park, USA.
  • Merchant A; Division of Medical Oncology, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, USA.
  • Reckamp KL; Division of Medical Oncology, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, USA. Electronic address: Karen.Reckamp@cshs.org.
Ann Oncol ; 33(1): 109-111, 2022 01.
Article in English | MEDLINE | ID: covidwho-1471877
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 / Neoplasms Topics: Vaccines Limits: Humans Language: English Journal: Ann Oncol Journal subject: Neoplasms Year: 2022 Document Type: Article

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 / Neoplasms Topics: Vaccines Limits: Humans Language: English Journal: Ann Oncol Journal subject: Neoplasms Year: 2022 Document Type: Article